Chikungunya recombinant subunit vaccine

Ended Project Grant Awarded Last action

Award ID
R44AI120388
Recipient
Awarding agency
Obligated
$9,815,707

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $8,815,707.00 Federal
  • $1,000,000.00 Non-federal
Place of performance
Hawaii, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $998,229 $0
Amendment $998,229 $0
Amendment $0 $0
Amendment $0 $0
Amendment $48,963 $0
Amendment $48,963 $0
Amendment $48,963 $0
Amendment $918,090 $0
Amendment $918,090 $0
Amendment $918,090 $0
Amendment $918,090 $0
Amendment $1,000,000 $0
Amendment Chikungunya recombinant subunit vaccine - 7. Project summary/abstract chikungunya virus (CHIKV) is an alphavirus classified as a category C priority pathogen… $1,000,000 $1,000,000
Amendment $148,154 $0
Amendment -$148,154 $0
Original award $1,000,000 $0
Show all 17

Quick answers

Who received award R44AI120388?

R44AI120388 was awarded to Hawaii Biotech, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 22, 2016.

How much is award R44AI120388 worth?

$9,815,707 has been obligated on R44AI120388: $8,815,707 in federal funding and $1,000,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award